PAR paradigm biopharmaceuticals limited..

Ann: Notice of General Meeting/Proxy Form, page-85

  1. 1,506 Posts.
    lightbulb Created with Sketch. 185
    Hi Hunter, I agree that they won't be able to fund P3 through CR, and that the crunch time is now. PR has to get funding from somewhere sooner or later. But what do you make of the resolution that allow them more capacity to do issue more equity? Normally, with CR, they are very discreet about it, and launch at the very last minute, which contrast to this open and transparent tilt at it this time around.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
31.0¢
Change
0.020(6.90%)
Mkt cap ! $120.7M
Open High Low Value Volume
29.0¢ 31.0¢ 28.0¢ $97.62K 331.4K

Buyers (Bids)

No. Vol. Price($)
2 74197 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 54675 2
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.